Indian drugmakers gear up for ₹600-800 cr insulin pen market post-Novo exit (Soban News)

Novo Nordisk to phase out insulin pens and cartridges in India; Eris, Wockhardt and Lupin prepare to capture Rs 600-800 crore market opportunity from FY26 onwards​Novo Nordisk to phase out insulin pens and cartridges in India; Eris, Wockhardt and Lupin prepare to capture Rs 600-800 crore market opportunity from FY26 onwards ​Latest News [ SOBAN NEWS: International and National ]